The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.
A pandemic is not inevitable, scientists say. But the outbreak has passed worrisome milestones in recent weeks.
SCIENCE: Trudeau Institute, Ampersand Biosciences producing tools for flu research with $1M grant SARANAC LAKE — Local research and biotechnology laboratories Trudeau Institute and Ampersand ...
NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today announced that it has engaged a Clinical Research Organization (CRO) to conduct a Phase II clinical trial advancing its broad-spectrum ...
A pandemic is not inevitable, scientists say. But the outbreak has passed worrisome milestones in recent weeks, including ...
Last Friday, HHS announced it will provide approximately $590 million to Moderna to accelerate the development of mRNA-based ...
No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...
Traws Pharma (TRAW) announced completion of Phase I clinical studies of its investigational one-dose influenza therapy, tivoxavir marboxil, for ...
8d
According to the latest data from the Centers for Disease Control, the current bird flu outbreak has caused 67 human cases of ...
The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of ...
Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...
Earlier this month, Moderna announced business updates and progress across its pipeline. Moderna says it enters 2025 with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback